https://www.stcccv.org.tn/web/app_dev123.php/seo/1

DefaultController :: seoAction

Request

GET Parameters

No GET parameters

POST Parameters

No POST parameters

Request Attributes

Key Value
_controller
"SeoBundle\Controller\DefaultController::seoAction"
_route
"seo"
_route_params
[
  "page" => "1"
]
page
"1"

Request Headers

Header Value
accept
"*/*"
accept-charset
"ISO-8859-1,utf-8;q=0.7,*;q=0.7"
accept-encoding
"gzip, br, deflate"
accept-language
"en-us,en;q=0.5"
cookie
"PHPSESSID=7c275e6f71e5a94453b6c82efead9fdb"
forwarded
"for="20.171.207.44";host="www.stcccv.org.tn";proto=https"
from
"gptbot(at)openai.com"
host
"www.stcccv.org.tn"
remote-ip
"20.171.207.44"
user-agent
"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; GPTBot/1.2; +https://openai.com/gptbot)"
x-forwarded-for
"20.171.207.44"
x-openai-host-hash
"980094447"
x-ovhrequest-id
"1ea20cc5dfcacc7a84be5d1e15d6e24d"
x-php-ob-level
2
x-predictor
"1"

Request Content

Request content not available (it was retrieved as a resource).

Server Parameters

Key Value
APP_ENGINE
"php"
APP_ENGINE_VERSION
"7.3"
CFG_CLUSTER
"cluster023"
DOCUMENT_ROOT
"/home/stcccvorud/www/site"
ENVIRONMENT
"production"
FCGI_ROLE
"RESPONDER"
GATEWAY_INTERFACE
"CGI/1.1"
GEOIP_AREA_CODE
"0"
GEOIP_COUNTRY_CODE
"US"
GEOIP_COUNTRY_NAME
"United States"
GEOIP_DMA_CODE
"0"
GEOIP_LATITUDE
"37.750999"
GEOIP_LONGITUDE
"-97.821999"
HTTPS
"on"
HTTP_ACCEPT
"*/*"
HTTP_ACCEPT_CHARSET
"ISO-8859-1,utf-8;q=0.7,*;q=0.7"
HTTP_ACCEPT_ENCODING
"gzip, br, deflate"
HTTP_ACCEPT_LANGUAGE
"en-us,en;q=0.5"
HTTP_COOKIE
"PHPSESSID=7c275e6f71e5a94453b6c82efead9fdb"
HTTP_FORWARDED
"for="20.171.207.44";host="www.stcccv.org.tn";proto=https"
HTTP_FROM
"gptbot(at)openai.com"
HTTP_HOST
"www.stcccv.org.tn"
HTTP_REMOTE_IP
"20.171.207.44"
HTTP_USER_AGENT
"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; GPTBot/1.2; +https://openai.com/gptbot)"
HTTP_X_FORWARDED_FOR
"20.171.207.44"
HTTP_X_OPENAI_HOST_HASH
"980094447"
HTTP_X_OVHREQUEST_ID
"1ea20cc5dfcacc7a84be5d1e15d6e24d"
HTTP_X_PREDICTOR
"1"
MAGIC_QUOTES
"0"
PATH_INFO
""
PATH_TRANSLATED
"redirect:/web/Home/hightlights/3/show/hightlights/3/show"
PHP_SELF
"/web/app_dev123.php/Home/hightlights/3/show"
PHP_VER
"5_3"
QUERY_STRING
""
REGISTER_GLOBALS
"0"
REMOTE_ADDR
"127.0.0.1"
REMOTE_PORT
"34908"
REQUEST_METHOD
"GET"
REQUEST_TIME
1750696442
REQUEST_TIME_FLOAT
1750696442.4225
REQUEST_URI
"/web/app_dev123.php/seo/1"
SCRIPT_FILENAME
"/home/stcccvorud/www/site/web/app_dev123.php"
SCRIPT_NAME
"/web/app_dev123.php"
SCRIPT_URI
"https://www.stcccv.org.tn:443/web/app_dev123.php/Home/hightlights/3/show"
SCRIPT_URL
"/web/app_dev123.php/Home/hightlights/3/show"
SERVER_ADDR
"10.23.40.125"
SERVER_ADMIN
"postmaster@www.stcccv.org.tn"
SERVER_NAME
"www.stcccv.org.tn"
SERVER_PORT
"443"
SERVER_PROTOCOL
"HTTP/1.1"
SERVER_SIGNATURE
""
SERVER_SOFTWARE
"Apache"
UNIQUE_ID
"aFmB@soJQtGesxFvyvXeNgAAAXM"
USER
"stcccvorud"
ZEND_OPTIMIZER
"1"
argc
0
argv
[]

Response

Response Headers

Header Value
cache-control
"no-cache, private"
date
"Mon, 23 Jun 2025 16:34:02 GMT"
x-debug-token
"aed6c0"

Cookies

Request Cookies

Key Value
PHPSESSID
"7c275e6f71e5a94453b6c82efead9fdb"

Response Cookies

No response cookies

Session

Session Metadata

Key Value
Created
"Mon, 23 Jun 25 18:32:07 +0200"
Last used
"Mon, 23 Jun 25 18:34:00 +0200"
Lifetime
"0"

Session Attributes

Attribute Value
_csrf/https-form
"cz3bc3PRx309pravbxXPfNBOKRvBxuXQKKknmAU2zsg"
_locale
"fr"

Flashes

Flashes

No flash messages were created.

Parent Request

Return to parent request (token = dd6a5a)

Key Value
_controller
"Gestion\MetierBundle\Controller\HightlightsController::showAction"
_firewall_context
"security.firewall.map.context.main"
_route
"hightlights_show"
_route_params
[
  "id" => "3"
]
hightlight
Hightlights {#622
  -id: 3
  -titre: "GLOBAL LEADERS, sous-groupe d’angioplastie complexe : Ticagrelor monothérapie dans les angioplasties complexes (multitronculaire, lésions longues, bifurcation) (étude présentée par Patrick Serruys)"
  -titreEn: null
  -description: """
    <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Times New Roman&quot;,serif">C&rsquo;est une &eacute;tude de sup&eacute;riorit&eacute;, ouverte randomis&eacute;e, multicentrique, r&eacute;alis&eacute;e chez 15968 patients (maladie coronaire stable ou SCA). Le sous-groupe d&rsquo;angioplastie complexe repr&eacute;sente 4570 patients.</span></span></span></span></p>\r\n
    \r\n
    <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Times New Roman&quot;,serif">Le crit&egrave;re de jugement primaire composite&nbsp;: tout d&eacute;c&egrave;s, IDM non fatal &agrave; 24 mois et le crit&egrave;re secondaire&nbsp;: saignement BARC 3 ou 5</span></span></span></span></p>\r\n
    \r\n
    <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Times New Roman&quot;,serif">L&rsquo;objectif est de comparer une strat&eacute;gie standard (12 mois de DAPT&nbsp;: Aspirine + Clopidogrel ou Ticagrelor suivi de 12 mois d&rsquo;aspirine) &agrave; une strat&eacute;gie exp&eacute;rimentale (1 mois de DAPT&nbsp;: aspirine+ Ticagrelor, suivi de 23 mois de Ticagrelor seul)</span></span></span></span></p>\r\n
    \r\n
    <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:&quot;Times New Roman&quot;,serif">Dans l&rsquo;&eacute;tude Globale, il n&rsquo;y avait pas de diff&eacute;rence entre les deux strat&eacute;gies de point vue crit&egrave;re primaire et secondaire, par contre dans cette sous &eacute;tude d&rsquo;ATL complexe, la strat&eacute;gie exp&eacute;rimentale &eacute;tait sup&eacute;rieure en mati&egrave;re de crit&egrave;re primaire (HR= 0,64(0,48-0,85), p=0,015) sans qu&rsquo;il y ait de majoration du risque d&rsquo;h&eacute;morragie. De ce fait la strat&eacute;gie d&rsquo;un mois de DAPT suivie de 23 mois de Ticagrelor pourrait &ecirc;tre une bonne alternative chez les patients avec ATL complexe. </span></span></span></span></p>
    """
  -descriptionEn: null
  -descriptionSansEditeur: "C’est une étude de supériorité, ouverte randomisée, multicentrique, réalisée chez 15968 patients (maladie coronaire stable ou SCA). Le sous-groupe d’angioplastie complexe représente 4570 patients. Le critère de jugement primaire composite : tout décès, IDM non fatal à 24 mois et le critère secondaire : saignement BARC 3 ou 5"
  -titrePhoto: "Session « Innovations in complex multivessel disease PCI – SYNTAX II strategy and beyond », 23 Mai, Europcr 2019"
  -categorieHightlights: CategorieHightlights {#576 …}
  -affiche: "highlights7.JPG"
  -file: null
  #photoHightlights: PersistentCollection {#583 …}
}
id
"3"